Skip to main content
Top
Published in: International Ophthalmology 5/2010

01-10-2010 | Case Report

CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis

Authors: Ilknur Tugal-Tutkun, Bilge Araz, Atahan Cagatay

Published in: International Ophthalmology | Issue 5/2010

Login to get access

Abstract

We report the case of a patient with Behçet’s uveitis who developed cytomegalovirus (CMV) retinitis after intravitreal triamcinolone acetonide (IVTA) injection. We reviewed the patient’s chart for the purpose of this report. An IVTA injection was performed for treatment of severe panuveitis in the left eye of a 30-year-old male patient with Behçet’s disease. Systemic treatment included high dose corticosteroid and azathioprine. Fourteen weeks after IVTA, extensive areas of necrotizing retinitis developed in the left eye. Polymerase chain reaction of serum and vitreous samples was positive for CMV DNA. Serum anti-CMV IgG was positive, IgM was negative, anti-HIV antibody was negative, complete blood count was normal, and CD4 count was 1,060 cells/μl. The patient responded well to intravitreal ganciclovir injection performed twice and intravenous ganciclovir treatment administered for five weeks. Local immunosuppression with IVTA may cause CMV retinitis. Awareness of this serious complication is important for correct diagnosis and treatment.
Literature
2.
go back to reference Sloan DJ, Taegtmeyer M, Pearce IA et al (2008) Cytomegalovirus retinitis in the absence of HIV or immunosuppression. Eur J Ophthalmol 18:813–815PubMed Sloan DJ, Taegtmeyer M, Pearce IA et al (2008) Cytomegalovirus retinitis in the absence of HIV or immunosuppression. Eur J Ophthalmol 18:813–815PubMed
3.
go back to reference Stewart MW, Bolling JP, Mendez JC (2005) Cytomegalovirus retinitis in an immunocompetent patient. Arch Ophthalmol 123:572–574CrossRefPubMed Stewart MW, Bolling JP, Mendez JC (2005) Cytomegalovirus retinitis in an immunocompetent patient. Arch Ophthalmol 123:572–574CrossRefPubMed
4.
go back to reference Ufret-Vincenty RL, Singh RP, Lowder C, Kaiser PK (2007) Cytomegalovirus retinitis after fluocinolone acetonide (RetisertTM) implant. Am J Ophthalmol 143:334–335CrossRefPubMed Ufret-Vincenty RL, Singh RP, Lowder C, Kaiser PK (2007) Cytomegalovirus retinitis after fluocinolone acetonide (RetisertTM) implant. Am J Ophthalmol 143:334–335CrossRefPubMed
5.
go back to reference Delyfer MN, Rougier MB, Hubschman JP et al (2007) Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand 85:681–683CrossRefPubMed Delyfer MN, Rougier MB, Hubschman JP et al (2007) Cytomegalovirus retinitis following intravitreal injection of triamcinolone: report of two cases. Acta Ophthalmol Scand 85:681–683CrossRefPubMed
6.
go back to reference Saidel MA, Berreen J, Margolis TP (2005) Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol 140:1141–1143CrossRefPubMed Saidel MA, Berreen J, Margolis TP (2005) Cytomegalovirus retinitis after intravitreous triamcinolone in an immunocompetent patient. Am J Ophthalmol 140:1141–1143CrossRefPubMed
7.
go back to reference Park YS, Byeon SH (2008) Cytomegalovirus retinitis after ıntravitreous triamcinolone ınjection in a patient with central retinal vein occlusion. Korean J Ophthalmol 22:143–144CrossRefPubMed Park YS, Byeon SH (2008) Cytomegalovirus retinitis after ıntravitreous triamcinolone ınjection in a patient with central retinal vein occlusion. Korean J Ophthalmol 22:143–144CrossRefPubMed
8.
go back to reference Sekiryu T, Iida T, Kaneko H, Saito M (2008) Cytomegalovirus retinitis after ıntravitreal triamcinolone acetonide in an ımmunocompetent patient. Jpn J Ophthalmol 52:407–425CrossRef Sekiryu T, Iida T, Kaneko H, Saito M (2008) Cytomegalovirus retinitis after ıntravitreal triamcinolone acetonide in an ımmunocompetent patient. Jpn J Ophthalmol 52:407–425CrossRef
9.
go back to reference Tuncer S, Yilmaz S, Urgancıoglu M, Tugal-Tutkun I (2007) Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet disease. J Ocul Pharmacol Ther 23:395–401CrossRefPubMed Tuncer S, Yilmaz S, Urgancıoglu M, Tugal-Tutkun I (2007) Results of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of panuveitis attacks in patients with Behçet disease. J Ocul Pharmacol Ther 23:395–401CrossRefPubMed
10.
go back to reference Mikami S, Nakase H, Ueno S et al (2007) Involvement of cytomegalovirus infection in the ileal lesions of the patient with Behçet’s disease. Inflamm Bowel Dis 13:802–803CrossRefPubMed Mikami S, Nakase H, Ueno S et al (2007) Involvement of cytomegalovirus infection in the ileal lesions of the patient with Behçet’s disease. Inflamm Bowel Dis 13:802–803CrossRefPubMed
11.
go back to reference Aggermann T, Stolba U, Brunner S, Binder S (2006) Endophthalmitis with retinitis following intravitreal triamcinolone acetonide injection. Ophthalmologica 220:131–133CrossRefPubMed Aggermann T, Stolba U, Brunner S, Binder S (2006) Endophthalmitis with retinitis following intravitreal triamcinolone acetonide injection. Ophthalmologica 220:131–133CrossRefPubMed
12.
go back to reference Toh T, Borthwick JH (2006) Acute retinal necrosis post intravitreal injection of triamcinolone acetonide. Clin Exp Ophthalmol 34:380–382CrossRef Toh T, Borthwick JH (2006) Acute retinal necrosis post intravitreal injection of triamcinolone acetonide. Clin Exp Ophthalmol 34:380–382CrossRef
Metadata
Title
CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis
Authors
Ilknur Tugal-Tutkun
Bilge Araz
Atahan Cagatay
Publication date
01-10-2010
Publisher
Springer Netherlands
Published in
International Ophthalmology / Issue 5/2010
Print ISSN: 0165-5701
Electronic ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-009-9332-9

Other articles of this Issue 5/2010

International Ophthalmology 5/2010 Go to the issue